(RI) Pernod Ricard S.A. - Overview
Sector: Consumer Defensive | Industry: Beverages - Wineries & Distilleries | Exchange: PA (France) | Market Cap: 16.872m EUR | Total Return: -24.2% in 12m
Whiskey, Vodka, Gin, Rum, Liqueur
Total Rating 45
Safety 83
Buy Signal 0.17
Beverages - Wineries & Distilleries
Industry Rotation: +20.8
Industry Rotation: +20.8
Market Cap:
19.9B
Avg Turnover: 59.9M EUR
Avg Turnover: 59.9M EUR
ATR:
3.23%
Peers RS (IBD): 10.0
Peers RS (IBD): 10.0
Risk 5d forecast
Volatility33.4%
Rel. Tail Risk-12.1%
Reward TTM
Sharpe Ratio-1.01
Alpha-30.45
Character TTM
Beta0.090
Beta Downside0.362
Drawdowns 3y
Max DD68.52%
CAGR/Max DD-0.43
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Description: RI Pernod Ricard S.A.
Pernod Ricard S.A. (ticker RI) is a global producer and distributor of wines, spirits, and a growing line of non-alcoholic beverages. Its portfolio spans iconic brands such as Absolut, Chivas, Jameson, Martell, and Pernod, alongside newer zero-alcohol offerings like Beefeater 0% and Ceder’s, covering categories from whisky and vodka to champagne and aperitifs.
In FY 2023 the group generated €10.2 billion in net sales, reflecting a 7% year-over-year increase and 5.5% organic growth, while adjusted EBITDA margin held steady at 22.3%. Net debt stood at €4.1 billion, giving a net-debt-to-equity ratio of roughly 0.45, indicating a manageable leverage profile.
Key sector drivers include continued premiumisation-premium-segment spirits grew 9% in 2023-and a resurgence in European on-trade consumption post-pandemic. Emerging-market demand, particularly for high-end whisky in China and India, remains a growth catalyst, while inflation-linked price pressures are being offset by strong brand pricing power.
For deeper quantitative insights, you might explore ValueRay’s detailed analyst toolkit.
- Premium spirits demand drives revenue growth
- Emerging markets expansion boosts sales volume
- Raw material costs impact profit margins
- Alcohol consumption trends influence product mix
- Regulatory changes in key markets pose risk
Piotroski VR‑10 (Strict)
8.0
| Net Income: 3.17b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.01 > 1.0 |
| NWC/Revenue: 36.65% < 20% (prev 54.92%; Δ -18.27% < -1%) |
| CFO/TA 0.09 > 3% & CFO 3.52b > Net Income 3.17b |
| Net Debt (11.54b) to EBITDA (6.15b): 1.88 < 3 |
| Current Ratio: 2.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (252.1m) vs 12m ago 0.32% < -2% |
| Gross Margin: 59.81% > 18% (prev 0.60%; Δ 5.92k% > 0.5%) |
| Asset Turnover: 52.87% > 50% (prev 29.60%; Δ 23.28% > 0%) |
| Interest Coverage Ratio: 5.55 > 6 (EBITDA TTM 6.15b / Interest Expense TTM 997.5m) |
Altman Z''
4.71
| A: 0.20 (Total Current Assets 13.04b - Total Current Liabilities 5.60b) / Total Assets 37.68b |
| B: 0.36 (Retained Earnings 13.42b / Total Assets 37.68b) |
| C: 0.14 (EBIT TTM 5.54b / Avg Total Assets 38.43b) |
| D: 1.23 (Book Value of Equity 25.94b / Total Liabilities 21.15b) |
| Altman-Z'' Score: 4.71 = AA |
Beneish M
-2.70
| DSRI: 0.76 (Receivables 2.10b/1.58b, Revenue 20.32b/11.60b) |
| GMI: 1.01 (GM 59.81% / 60.14%) |
| AQI: 0.98 (AQ_t 0.54 / AQ_t-1 0.55) |
| SGI: 1.75 (Revenue 20.32b / 11.60b) |
| TATA: -0.01 (NI 3.17b - CFO 3.52b) / TA 37.68b) |
| Beneish M-Score: -2.70 (Cap -4..+1) = A |
What is the price of RI shares?
As of April 17, 2026, the stock is trading at EUR 66.64 with a total of 789,178 shares traded.
Over the past week, the price has changed by +3.13%, over one month by -1.42%, over three months by -11.00% and over the past year by -24.24%.
Over the past week, the price has changed by +3.13%, over one month by -1.42%, over three months by -11.00% and over the past year by -24.24%.
Is RI a buy, sell or hold?
Pernod Ricard S.A. has no consensus analysts rating.
What are the forecasts/targets for the RI price?
| Analysts Target Price | - | - |
Pernod Ricard S.A. (RI) - Fundamental Data Overview
as of 16 April 2026
Market Cap USD = 19.92b (16.87b EUR * 1.1807 EUR.USD)P/E Trailing = 11.9857
P/E Forward = 10.7759
P/S = 1.6811
P/B = 1.085
P/EG = 1.7291
Revenue TTM = 20.32b EUR
EBIT TTM = 5.54b EUR
EBITDA TTM = 6.15b EUR
Long Term Debt = 11.60b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.68b EUR (from shortTermDebt, last quarter)
Debt = 13.93b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.54b EUR (from netDebt column, last quarter)
Enterprise Value = 28.41b EUR (16.87b + Debt 13.93b - CCE 2.40b)
Interest Coverage Ratio = 5.55 (Ebit TTM 5.54b / Interest Expense TTM 997.5m)
EV/FCF = 12.60x (Enterprise Value 28.41b / FCF TTM 2.25b)
FCF Yield = 7.94% (FCF TTM 2.25b / Enterprise Value 28.41b)
FCF Margin = 11.10% (FCF TTM 2.25b / Revenue TTM 20.32b)
Net Margin = 15.62% (Net Income TTM 3.17b / Revenue TTM 20.32b)
Gross Margin = 59.81% ((Revenue TTM 20.32b - Cost of Revenue TTM 8.17b) / Revenue TTM)
Gross Margin QoQ = 59.28% (prev 57.35%)
Tobins Q-Ratio = 0.75 (Enterprise Value 28.41b / Total Assets 37.68b)
Interest Expense / Debt = 1.74% (Interest Expense 243.0m / Debt 13.93b)
Taxrate = 26.25% (357.0m / 1.36b)
NOPAT = 4.08b (EBIT 5.54b * (1 - 26.25%))
Current Ratio = 2.33 (Total Current Assets 13.04b / Total Current Liabilities 5.60b)
Debt / Equity = 0.90 (Debt 13.93b / totalStockholderEquity, last quarter 15.47b)
Debt / EBITDA = 1.88 (Net Debt 11.54b / EBITDA 6.15b)
Debt / FCF = 5.12 (Net Debt 11.54b / FCF TTM 2.25b)
Total Stockholder Equity = 15.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.26% (Net Income 3.17b / Total Assets 37.68b)
RoE = 20.16% (Net Income TTM 3.17b / Total Stockholder Equity 15.74b)
RoCE = 20.25% (EBIT 5.54b / Capital Employed (Equity 15.74b + L.T.Debt 11.60b))
RoIC = 14.24% (NOPAT 4.08b / Invested Capital 28.67b)
WACC = 4.03% (E(16.87b)/V(30.80b) * Re(6.30%) + D(13.93b)/V(30.80b) * Rd(1.74%) * (1-Tc(0.26)))
Discount Rate = 6.30% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -33.33 | Cagr: -0.26%
[DCF] Terminal Value 88.44% ; FCFF base≈1.66b ; Y1≈2.05b ; Y5≈3.50b
[DCF] Fair Price = 357.2 (EV 101.49b - Net Debt 11.54b = Equity 89.96b / Shares 251.8m; r=6.0% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 7.23 | EPS CAGR: -45.54% | SUE: 0.0 | # QB: 0
Revenue Correlation: -34.83 | Revenue CAGR: -5.45% | SUE: N/A | # QB: 0
EPS current Year (2026-06-30): EPS=5.85 | Chg7d=-0.018 | Chg30d=-0.026 | Revisions Net=-4 | Growth EPS=-19.4% | Growth Revenue=-12.5%
EPS next Year (2027-06-30): EPS=6.04 | Chg7d=-0.013 | Chg30d=-0.022 | Revisions Net=-4 | Growth EPS=+3.1% | Growth Revenue=+0.6%
[Analyst] Revisions Ratio: -0.33 (4 Up / 8 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -0.4% (Discount Rate 7.9% - Earnings Yield 8.3%)
[Growth] Growth Spread = +1.1% (Analyst 0.6% - Implied -0.4%)